Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A support vector machine approach to assess drug efficacy of interferon-alpha and ribavirin combination therapy.

Molecular diagnosis & therapy - 1 Jan 2008

Lin Eugene, Hwang Yuchi

Abstract excerpt

BACKGROUND: Interferon-alpha (IFNalpha) in combination with ribavirin can be used for the treatment of patients with chronic hepatitis C. This therapeutic approach achieves an overall sustained response rate of approximately 40%, but treatment takes 6-12 months and patients often experience significant adverse reactions. OBJECTIVE: We aim to develop a tool to distinguish potential responders from nonresponders...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Therapy, Combination
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Neural Networks, Computer

Share to Ribavirin

Share to Viral Load

Source

Identifiers

PMID: 18652518
DOI: 10.1007/BF03256287

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A support vector machine approach to assess drug efficacy of interferon-alpha and ribavirin combination therapy.PMID 18652518Read ↗

An artificial neural network approach to the drug efficacy of interferon treatments.Semantic proximity Read ↗

Efficacy of interferon treatment for chronic hepatitis C predicted by feature subset selection and support vector machine.Semantic proximity Read ↗

A machine learning-based treatment prediction model using whole genome variants of hepatitis C virus.Semantic proximity Read ↗

Prediction of hepatitis C virus interferon/ribavirin therapy outcome based on viral nucleotide attributes using machine learning algorithms.Semantic proximity Read ↗

Prediction of prognostic biomarkers for interferon-based therapy to hepatitis C virus patients: a meta-analysis of the NS5A protein in subtypes 1a, 1b, and 3a.Semantic proximity Read ↗

Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis.Semantic proximity Read ↗

A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients.Semantic proximity Read ↗

Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C.Semantic proximity Read ↗

A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy.Semantic proximity Read ↗

Sequences in the interferon sensitivity-determining region and core region of hepatitis C virus impact pretreatment prediction of response to PEG-interferon plus ribavirin: data mining analysis.Semantic proximity Read ↗

The development of an expert system to predict virological response to HIV therapy as part of an online treatment support tool.Semantic proximity Read ↗

The development of artificial neural networks to predict virological response to combination HIV therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.